These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
335 related items for PubMed ID: 28567194
1. Prevalence of antibody to hepatitis B core antigen among hepatitis B surface antigen-negative blood donors in Ilorin, Nigeria: A cross-sectional study. Ogunfemi MK, Olawumi HO, Olokoba AB, Kagu MB, Biliaminu SA, Durowade KA, Durotoye IA, Shittu AO. Malawi Med J; 2017 Mar; 29(1):32-36. PubMed ID: 28567194 [Abstract] [Full Text] [Related]
2. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria. Jeremiah ZA, Idris H, Ajayi BB, Ezimah AC, Malah MB, Baba MM. Hum Antibodies; 2011 Mar; 20(3-4):77-82. PubMed ID: 22129677 [Abstract] [Full Text] [Related]
3. Hepatitis B core IgM antibody (anti-HBcIgM) among hepatitis B surface antigen (HBsAg) negative blood donors in Nigeria. Japhet MO, Adesina OA, Donbraye E, Adewumi MO. Virol J; 2011 Nov 10; 8():513. PubMed ID: 22074048 [Abstract] [Full Text] [Related]
4. Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti-HBcore and IgM anti-HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria. Akinbami AA, Oshinaike OO, Dosunmu OA, Adeyemo TA, Adediran A, Akanmu S, Wright KO, Ilori S, Aile K. BMC Res Notes; 2012 Mar 28; 5():167. PubMed ID: 22455501 [Abstract] [Full Text] [Related]
5. Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature. Hedayati-Moghaddam MR, Tehranian F, Mosavat A, Miri R, Ahmadi Ghezeldasht S. Arch Iran Med; 2024 Jun 01; 27(6):305-312. PubMed ID: 38855800 [Abstract] [Full Text] [Related]
6. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study. Alizadeh Z, Milani S, Sharifi Z. Arch Iran Med; 2014 Feb 01; 17(2):106-7. PubMed ID: 24527970 [Abstract] [Full Text] [Related]
7. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Transfusion; 2007 Jan 01; 47(1):74-9. PubMed ID: 17207233 [Abstract] [Full Text] [Related]
8. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors. Muselmani W, Habbal W, Monem F. Transfus Med; 2013 Aug 01; 23(4):265-8. PubMed ID: 23621787 [Abstract] [Full Text] [Related]
9. Prevalence of "anti-HBc alone" among Syrian blood donors. Muselmani W, Habbal W, Monem F. J Infect Dev Ctries; 2014 Aug 13; 8(8):1013-5. PubMed ID: 25116667 [Abstract] [Full Text] [Related]
10. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO. Virol J; 2016 May 05; 13():76. PubMed ID: 27150469 [Abstract] [Full Text] [Related]
11. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks. Oluyinka OO, Tong HV, Bui Tien S, Fagbami AH, Adekanle O, Ojurongbe O, Bock CT, Kremsner PG, Velavan TP. PLoS One; 2015 May 05; 10(7):e0131912. PubMed ID: 26148052 [Abstract] [Full Text] [Related]
12. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A. Indian J Med Res; 2006 Jan 05; 123(1):37-42. PubMed ID: 16567866 [Abstract] [Full Text] [Related]
13. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors. Karimi G, Zadsar M, Vafaei N, Sharifi Z, FalahTafti M. Virol J; 2016 Mar 05; 13():36. PubMed ID: 26944046 [Abstract] [Full Text] [Related]
14. Hepatitis B viral markers in surface antigen negative blood donors: the need to look beyond antibody negativity. Salawu L, Adegoke AO, Aboderin AO, Huraina HA. West Afr J Med; 2011 Mar 05; 30(4):292-5. PubMed ID: 22669836 [Abstract] [Full Text] [Related]
15. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply. Zheng X, Ye X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP. Transfusion; 2015 Apr 05; 55(4):890-7. PubMed ID: 25363504 [Abstract] [Full Text] [Related]
16. Hepatitis B virus screening in contacts of blood donors with antibodies against core protein (anti-HBC), but without surface antigen (HBsAg). Fortes HM, Ribeiro LC, Perazolo GF, Souto FJ. Mem Inst Oswaldo Cruz; 2006 Mar 05; 101(2):195-9. PubMed ID: 16830712 [Abstract] [Full Text] [Related]
17. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China. Ye X, Li T, Xu X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP. Blood Transfus; 2017 Jan 05; 15(1):6-12. PubMed ID: 27416568 [Abstract] [Full Text] [Related]
18. [Significance of hepatitis B core antibody as the only marker of hepatitis B infection]. Colomina-Rodríguez J, González-García D, Burgos-Teruel A, Fernández-Lorenz N, Guerrero-Espejo A. Enferm Infecc Microbiol Clin; 2005 Feb 05; 23(2):80-5. PubMed ID: 15743579 [Abstract] [Full Text] [Related]
19. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion. Asim M, Ali R, Khan LA, Husain SA, Singla R, Kar P. Indian J Med Res; 2010 Sep 05; 132():312-7. PubMed ID: 20847378 [Abstract] [Full Text] [Related]
20. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country. van de Laar TJ, Marijt-van der Kreek T, Molenaar-de Backer MW, Hogema BM, Zaaijer HL. Transfusion; 2015 Jun 05; 55(6):1206-13. PubMed ID: 25494685 [Abstract] [Full Text] [Related] Page: [Next] [New Search]